Bhatraju, Elenore P.
Kennedy, Devin N.
Gojic, Alexander J.
Iles-Shih, Matthew
Merrill, Joseph O.
Samet, Jeffrey H.
Hallgren, Kevin A.
Tsui, Judith I.
Clinical trials referenced in this document:
Documents that mention this clinical trial
mHealth Incentivized Adherence Plus Patient Navigation (MIAPP): protocol for a pilot randomized controlled trial to improve linkage and retention on buprenorphine for hospitalized patients with methamphetamine use and opioid use disorder
https://doi.org/10.1186/s13722-025-00538-1
Funding for this research was provided by:
National Institute on Drug Abuse (5K23DA058751-02, 1R34DA057609-01)
Article History
Received: 23 September 2024
Accepted: 21 January 2025
First Online: 29 January 2025
Declarations
:
: The MIAPP study received approval from the University of Washington’s Institutional Review Board (IRB) in Seattle, Washington. The study follows adverse event reporting procedures required by the National Institute on Drug Abuse (NIDA) and the institution’s IRB. This study is registered at ClinicalTrials.gov (NCT06027814).
: Not applicable.
: The authors declare no competing interests.